(ROP) Roper Technologies - Ratings and Ratios
Software, Meters, Dispensers, Sensors
ROP EPS (Earnings per Share)
ROP Revenue
Description: ROP Roper Technologies September 26, 2025
Roper Technologies (NASDAQ: ROP) is a diversified industrial conglomerate that designs, develops, and markets vertical-software solutions and technology-enabled products across North America, Europe, and Asia. Its portfolio is organized into three primary segments: Application Software, Network Software, and Technology-Enabled Products.
Application Software delivers enterprise-grade management, diagnostic, and laboratory information systems, as well as cloud-based platforms for K-12 education, transportation, financial compliance, payment processing, and insurance-industry analytics. The segment also supplies food-service technology and a specialized software suite for autism and intellectual-developmental-disability (IDD) care.
Network Software focuses on cloud-based data collaboration, estimating automation, visual-effects and 3D content tools, supply-chain management, health-care services, pharmacy solutions, and software for life-insurance and financial-services firms.
Technology-Enabled Products includes medical-device accessories (e.g., ultrasound procedure tools), industrial dispensers, wireless sensor networks, automated surgical-scrub and linen dispensers, precision measurement systems, RFID credential readers, and water-metering hardware.
Roper sells its offerings through a mix of direct sales offices, manufacturer representatives, resellers, and distributors, leveraging a decentralized go-to-market model that preserves high gross margins and recurring-revenue streams.
Key financial highlights (FY 2023): revenue of $7.5 billion, operating margin of ~15 %, free-cash-flow yield of ~6 %, and a recurring-revenue mix of ~70 %-metrics that underscore the company’s cash-generating stability and resilience to cyclical downturns.
Sector drivers that materially affect Roper include accelerating digital transformation in health-care and insurance (propelled by regulatory pressure for data transparency), sustained capital-expenditure growth in automation and precision-measurement equipment, and macro-level inflationary pressures that can boost pricing power for high-margin software subscriptions.
For a deeper quantitative assessment, you may find ValueRay’s platform useful for benchmarking ROP’s valuation metrics against peers.
ROP Stock Overview
| Market Cap in USD | 54,770m |
| Sub-Industry | Industrial Conglomerates |
| IPO / Inception | 1992-02-12 |
ROP Stock Ratings
| Growth Rating | 10.4% |
| Fundamental | 70.8% |
| Dividend Rating | 59.0% |
| Return 12m vs S&P 500 | -31.2% |
| Analyst Rating | 4.11 of 5 |
ROP Dividends
| Dividend Yield 12m | 0.74% |
| Yield on Cost 5y | 0.89% |
| Annual Growth 5y | 9.96% |
| Payout Consistency | 97.0% |
| Payout Ratio | 13.6% |
ROP Growth Ratios
| Growth Correlation 3m | -83.9% |
| Growth Correlation 12m | -38.5% |
| Growth Correlation 5y | 79.5% |
| CAGR 5y | 4.71% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.19 |
| CAGR/Mean DD 3y (Pain Ratio) | 1.14 |
| Sharpe Ratio 12m | 0.23 |
| Alpha | -36.88 |
| Beta | 1.001 |
| Volatility | 27.03% |
| Current Volume | 1164.9k |
| Average Volume 20d | 1075.5k |
| Stop Loss | 432.7 (-3%) |
| Signal | 0.53 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (1.54b TTM) > 0 and > 6% of Revenue (6% = 448.1m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 0.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -25.58% (prev -20.04%; Δ -5.54pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 2.41b > Net Income 1.54b (YES >=105%, WARN >=100%) |
| Net Debt (8.62b) to EBITDA (3.09b) ratio: 2.78 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.46 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (108.4m) change vs 12m ago 0.46% (target <= -2.0% for YES) |
| Gross Margin 68.87% (prev 69.90%; Δ -1.04pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 23.68% (prev 22.03%; Δ 1.66pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.99 (EBITDA TTM 3.09b / Interest Expense TTM 280.5m) >= 6 (WARN >= 3) |
Altman Z'' 3.00
| (A) -0.06 = (Total Current Assets 1.65b - Total Current Liabilities 3.56b) / Total Assets 33.22b |
| (B) 0.50 = Retained Earnings (Balance) 16.57b / Total Assets 33.22b |
| (C) 0.07 = EBIT TTM 2.24b / Avg Total Assets 31.53b |
| (D) 1.21 = Book Value of Equity 16.46b / Total Liabilities 13.59b |
| Total Rating: 3.00 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 70.84
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 3.66% = 1.83 |
| 3. FCF Margin 31.08% = 7.50 |
| 4. Debt/Equity 0.45 = 2.40 |
| 5. Debt/Ebitda 2.78 = -1.44 |
| 6. ROIC - WACC (= -2.01)% = -2.51 |
| 7. RoE 8.08% = 0.67 |
| 8. Rev. Trend 99.59% = 7.47 |
| 9. EPS Trend 98.32% = 4.92 |
What is the price of ROP shares?
Over the past week, the price has changed by -6.82%, over one month by -10.39%, over three months by -18.81% and over the past year by -16.52%.
Is Roper Technologies a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ROP is around 376.54 USD . This means that ROP is currently overvalued and has a potential downside of -15.6%.
Is ROP a buy, sell or hold?
- Strong Buy: 10
- Buy: 2
- Hold: 6
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the ROP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 596.8 | 33.8% |
| Analysts Target Price | 596.8 | 33.8% |
| ValueRay Target Price | 419.7 | -5.9% |
ROP Fundamental Data Overview October 25, 2025
P/E Trailing = 33.0096
P/E Forward = 26.3852
P/S = 7.3339
P/B = 2.7273
P/EG = 2.5891
Beta = 1.001
Revenue TTM = 7.47b USD
EBIT TTM = 2.24b USD
EBITDA TTM = 3.09b USD
Long Term Debt = 7.86b USD (from longTermDebt, last quarter)
Short Term Debt = 999.8m USD (from shortTermDebt, last quarter)
Debt = 8.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.62b USD (from netDebt column, last quarter)
Enterprise Value = 63.39b USD (54.77b + Debt 8.86b - CCE 242.4m)
Interest Coverage Ratio = 7.99 (Ebit TTM 2.24b / Interest Expense TTM 280.5m)
FCF Yield = 3.66% (FCF TTM 2.32b / Enterprise Value 63.39b)
FCF Margin = 31.08% (FCF TTM 2.32b / Revenue TTM 7.47b)
Net Margin = 20.62% (Net Income TTM 1.54b / Revenue TTM 7.47b)
Gross Margin = 68.87% ((Revenue TTM 7.47b - Cost of Revenue TTM 2.33b) / Revenue TTM)
Gross Margin QoQ = 69.22% (prev 68.71%)
Tobins Q-Ratio = 1.91 (Enterprise Value 63.39b / Total Assets 33.22b)
Interest Expense / Debt = 0.89% (Interest Expense 79.1m / Debt 8.86b)
Taxrate = 22.05% (107.0m / 485.3m)
NOPAT = 1.75b (EBIT 2.24b * (1 - 22.05%))
Current Ratio = 0.46 (Total Current Assets 1.65b / Total Current Liabilities 3.56b)
Debt / Equity = 0.45 (Debt 8.86b / totalStockholderEquity, last quarter 19.63b)
Debt / EBITDA = 2.78 (Net Debt 8.62b / EBITDA 3.09b)
Debt / FCF = 3.71 (Net Debt 8.62b / FCF TTM 2.32b)
Total Stockholder Equity = 19.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.63% (Net Income 1.54b / Total Assets 33.22b)
RoE = 8.08% (Net Income TTM 1.54b / Total Stockholder Equity 19.06b)
RoCE = 8.33% (EBIT 2.24b / Capital Employed (Equity 19.06b + L.T.Debt 7.86b))
RoIC = 6.44% (NOPAT 1.75b / Invested Capital 27.14b)
WACC = 8.45% (E(54.77b)/V(63.63b) * Re(9.70%) + D(8.86b)/V(63.63b) * Rd(0.89%) * (1-Tc(0.22)))
Discount Rate = 9.70% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.32%
[DCF Debug] Terminal Value 74.70% ; FCFE base≈2.22b ; Y1≈2.55b ; Y5≈3.55b
Fair Price DCF = 427.3 (DCF Value 45.99b / Shares Outstanding 107.6m; 5y FCF grow 17.15% → 3.0% )
EPS Correlation: 98.32 | EPS CAGR: 10.35% | SUE: 1.00 | # QB: 5
Revenue Correlation: 99.59 | Revenue CAGR: 14.16% | SUE: 0.93 | # QB: 1
Additional Sources for ROP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle